XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $142,000 | -29.0% | 58,025 | +18.4% | 0.04% | -31.4% |
Q2 2021 | $200,000 | -5.7% | 49,025 | +4.3% | 0.05% | -17.7% |
Q1 2021 | $212,000 | -6.2% | 47,025 | +2.2% | 0.06% | -21.5% |
Q4 2020 | $226,000 | -16.3% | 46,025 | +1.2% | 0.08% | -27.5% |
Q3 2020 | $270,000 | – | 45,500 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 4,172,459 | $24,743,000 | 2.02% |
Kamunting Street Capital Management, L.P. | 345 | $2,046,000 | 1.28% |
DELTEC ASSET MANAGEMENT LLC | 853,132 | $5,059,000 | 0.90% |
Alpine Global Management, LLC | 552,856 | $3,278,000 | 0.68% |
Kamunting Street Capital Management, L.P. | 100,000 | $593,000 | 0.37% |
Redmile Group, LLC | 2,397,441 | $14,217,000 | 0.26% |
IHT Wealth Management, LLC | 207,210 | $1,229,000 | 0.12% |
ArrowMark Colorado Holdings LLC | 2,075,387 | $12,307,000 | 0.12% |
GPS Wealth Strategies Group, LLC | 45,500 | $270,000 | 0.11% |
683 Capital Management, LLC | 233,600 | $1,385,000 | 0.10% |